The American Association for Cancer Research (AACR) has proclaimed that the recipient of the 13th annual AACR Team Science Award will be the St. Jude Children’s Research Hospital’s Cancer Control and Survivorship Program.
The award is presented to one outstanding team for its ground-breaking research contributing to the knowledge we have on cancer. The group will be acknowledged at the AACR’s annual meeting’s opening ceremony.
The Cancer Control and Survivorship Program is a research program which aims for betterment in the quality of life of people surviving childhood cancer. The program is led by Leslie L. Robison, Ph.D. who is the chair of the Department of Epidemiology & Cancer Control, and Melissa Hudson, MD, the director of the Division of Cancer Survivorship.
This research program carries out genetic, clinical and observational research, and turns the findings into efficient approaches aimed at reducing complications which are linked to the treatment, or the late impacts of childhood cancer.
“Advances during the past few decades in childhood cancer treatment have led to an entirely new population that was nearly nonexistent when St. Jude opened its doors in 1962,” stated James R. Downing. He is the president and chief executive officer of St. Jude. “The work of our Cancer Survivorship division has added volumes to what is known about surviving pediatric cancer and how we can improve therapies for the next generation of patients.”
Information gained from the group’s efforts has contributed to the design of modern-day pediatric cancer treatment strategies and given vital data that helps guide health surveillance and health-preserving mediations in long-term survivors.
The program preserves leading parts in the two major, National Cancer Institute-funded cohorts, St. Jude Lifetime Cohort Study (St. Jude LIFE) and the Childhood Cancer Survivor Study (CCSS). These researches have aided in important findings illustrating the extent childhood cancer experiences, together with the consequential weight of a lingering ailment and consequent neoplasms along with their influence on preterm mortality.